WZ4003: Selective NUAK1/2 Inhibitor for Cancer and Neurod...
2026-01-20
WZ4003 is a highly selective NUAK1/2 kinase inhibitor, enabling precise investigation of LKB1-activated NUAK signaling in cancer and neurodegeneration. Its nanomolar potency, validated mechanistic benchmarks, and defined solubility profile make it a cornerstone for cell migration and proliferation assays.